- 全部删除
您的购物车当前为空
Dabigatran etexilate (BIBR 1048) 是一种 Dabigatran 前药,具有口服活性。它具有抗凝作用,能够预防心房颤动引起的静脉血栓栓塞和中风。

Dabigatran etexilate (BIBR 1048) 是一种 Dabigatran 前药,具有口服活性。它具有抗凝作用,能够预防心房颤动引起的静脉血栓栓塞和中风。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 109 | In stock | |
| 5 mg | ¥ 218 | In stock | |
| 10 mg | ¥ 328 | In stock | |
| 25 mg | ¥ 582 | In stock | |
| 50 mg | ¥ 892 | In stock | |
| 100 mg | ¥ 1,320 | In stock | |
| 200 mg | ¥ 1,960 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 295 | In stock |
Dabigatran etexilate 相关产品
| 产品描述 | Dabigatran etexilate (BIBR 1048) is a thrombin inhibitor that binds to thrombin, blocking its thrombogenic activity and preventing thrombus formation. |
| 靶点活性 | DTI:4.5 nM (Ki) |
| 体外活性 | 大鼠静脉注射 Dabigatran(0.3,1 和3 mg/kg),恒河猴静脉注射Dabigatran(0.15,0.3和0.6 mg/Kg) 后,在活化部分以剂量依赖性方式延长凝血活酶时间.在猪体内Dabigatran etexilate口服剂量为20 mg/kg. |
| 体内活性 | Dabigatran对各种动物具有浓度依赖性抗凝血作用。Dabigatran能够可逆地抑制人凝血酶(Ki: 4.5 nM)和凝血酶诱导的血小板聚集(IC50= 10 nM)。 |
| 别名 | 达比加群酯, BIBR 1048 |
| 分子量 | 627.73 |
| 分子式 | C34H41N7O5 |
| CAS No. | 211915-06-9 |
| Smiles | CCCCCCOC(=O)N\N=C\c1ccc(NCc2nc3cc(ccc3n2C)C(=O)N(CCC(=O)OCC)c2ccccn2)cc1 |
| 密度 | 1.24 g/cm3 |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 116 mg/mL (184.79 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) Ethanol: 10 mg/mL (15.93 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
评论内容